Generali's latest annual general meeting has reinforced the group's strategy of combining strong underwriting and capital generation with increasingly shareholder-friendly capital management, while fine-tuning governance and incentives in ways that will matter to insurance professionals across Europe and beyond.

Underwriting performance and capital headroom

Shareholders approved 2025 financial statements showing net profit of €3.515 billion and a record operating result of around €8 billion. The key point is that this profitability was driven largely by technical performance – stronger P&C underwriting and improved life margins – rather than one‑off factors.

Generali closed 2025 with a Solvency II ratio of 219%, up from 210% a year earlier. That level of capital headroom gives the group meaningful flexibility on reinsurance buying, risk appetite and growth in capital‑intensive lines, while still supporting an aggressive capital‑return stance. It also reinforces Generali’s standing with counterparties, cedents and regulators as one of Europe’s better‑capitalized composites.

Signals on capital deployment

The approved dividend of €1.64 per share for 2025, payable from May 20, 2026, fits into a multi‑year commitment to grow dividends at a double‑digit compound pace through 2027. On top of that, the AGM authorized a new share buyback program of up to €500 million for cancellation, capped at 2% of share capital.

From a balance sheet and market‑structure perspective, this matters in two ways.

First, it indicates that management and the board see the current capital position as more than sufficient relative to risk and regulatory expectations. Second, it suggests Generali will continue to favour capital‑efficient growth (for example, fee‑based businesses and protection) over heavy expansion in long‑duration, capital‑intensive guarantees, unless returns are clearly compelling.

The buyback authorisation runs for 18 months and adds to existing treasury shares of about 3% of capital. Purchases will be executed within tight price bands and in conformity with EU and Italian rules, reinforcing that capital returns are being managed within a conservative governance framework.

Remuneration and incentives tied to solvency and performance

On the liability side of the balance sheet, the AGM signed off on the group’s remuneration policy and the 2026–2028 Long Term Incentive Plan (LTIP), alongside the “We SHARE 3” employee share ownership plan.

The structure of these plans is more important than the headline share numbers. LTIP metrics continue to link a substantial portion of senior management pay to earnings per share, capital generation and total shareholder return, subject to underpins on Solvency II and dividend capacity. That alignment tends to favour sustained underwriting discipline, tight reserve management and prudent reinsurance strategy over short‑term volume growth.

The employee share plan extends equity participation deeper into the organisation, which is increasingly relevant as Generali rolls out digital, data and AI initiatives that depend on retaining specialist talent in pricing, claims, risk and technology functions.

Statutory auditors and board‑appointment rules

The appointment of a new Board of Statutory Auditors and the accompanying Articles of Association changes speak directly to regulatory and investor expectations around governance in a systemically important insurer.

The new auditors – led by chair Carlo Schiavone – have confirmed that they meet independence requirements under Italian law and the Corporate Governance Code. Their role in overseeing financial reporting, reserve adequacy and internal control frameworks will remain central as Generali navigates evolving expectations from IVASS, EIOPA and other supervisors on topics ranging from climate risk to model governance.

Amendments to Articles 28.4, 28.6 and 28.10 refine the process for appointing the board of directors, particularly in relation to slates submitted by the outgoing board. This has practical implications for continuity of strategy and for how shareholder coalitions can influence board composition in future cycles – an increasingly live issue in European insurance, where activist and long‑term institutional investors are more closely scrutinising governance, risk oversight and sustainability.

Capital structure and market implications

The combination of a high‑teens Solvency II buffer, record operating earnings and an explicit multi‑year capital‑return framework reinforces Generali’s position as a stable counterparty with predictable capital policy. That is relevant in negotiations over multi‑year reinsurance structures, alternative capital solutions and large commercial programs, where counterparties pay close attention to an insurer’s solvency trajectory and shareholder pressures.

It also adds competitive pressure on peers that have less headroom or more volatile earnings to clarify their own capital‑management plans.

As large European composites increasingly use buybacks and rising dividends to optimise capital under Solvency II, the industry may see further divergence between groups that can consistently generate surplus capital and those that must retain earnings to meet regulatory and rating‑agency expectations.